Wealthcreatures.com
Sakar Healthcare 5% UC 173
Sakar Healthcare
Locked 🔒 in another 5% UC
182 💚
Locked 🔒 in another 5% UC
182 💚
Wealthcreatures.com
MFL 1195
MFL
RECENT LOWS - 1175
Today crossed major Resistance @1460
High - 1468
Q1FY23 Results - 21st July 2022
RECENT LOWS - 1175
Today crossed major Resistance @1460
High - 1468
Q1FY23 Results - 21st July 2022
Wealthcreatures.com
Sakar Healthcare Locked 🔒 in another 5% UC 182 💚
SAKAR HEALTHCARE
191
191
7⃣ Solid Reasons to Invest Now!
SHAREKHAN, by BNP PARIBAS
Advantage India - INVEST
The Nifty 50 has seen huge volatility, correcting by almost ~14% correction from its highs and by ~8% in 2022 year to date, mainly led by inflation-led interest rate hikes globally, surge in crude oil prices, recessionary fears in Europe and the US and not the least, sizeable FIIs outflows. Despite this sharp correction, Indian equities yet have still stayed ahead of the US and other developed markets in 2022 so far, as India continues to offer better prospects given a sustained economic recovery and corporate earnings. In this report, we highlight seven key reasons to invest in Indian equities:
1. Equity markets absorb & quickly adjust to interest rate hikes.
2. Inflationary pressures are already moderating significantly.
3. Valuations have turned favourable now.
4. Nifty valuations (on TTM) are close to March 2020 bottom now.
5. India is set for a multi-year upcycle with all three growth engines firing (real estate revival, infrastructure spending and corporate capex cycle).
6. Healthy growth trend in corporate profits.
7. India's among fastest-growing economies.
In addition, it is essential to not time the markets but rather stay invested in the right-quality stocks for handsome gains in the next 1-3 years.
So, we advise investors to start investing in quality stocks with sound earnings visibility with healthy corporate governance and reasonable valuations.
SHAREKHAN, by BNP PARIBAS
Advantage India - INVEST
The Nifty 50 has seen huge volatility, correcting by almost ~14% correction from its highs and by ~8% in 2022 year to date, mainly led by inflation-led interest rate hikes globally, surge in crude oil prices, recessionary fears in Europe and the US and not the least, sizeable FIIs outflows. Despite this sharp correction, Indian equities yet have still stayed ahead of the US and other developed markets in 2022 so far, as India continues to offer better prospects given a sustained economic recovery and corporate earnings. In this report, we highlight seven key reasons to invest in Indian equities:
1. Equity markets absorb & quickly adjust to interest rate hikes.
2. Inflationary pressures are already moderating significantly.
3. Valuations have turned favourable now.
4. Nifty valuations (on TTM) are close to March 2020 bottom now.
5. India is set for a multi-year upcycle with all three growth engines firing (real estate revival, infrastructure spending and corporate capex cycle).
6. Healthy growth trend in corporate profits.
7. India's among fastest-growing economies.
In addition, it is essential to not time the markets but rather stay invested in the right-quality stocks for handsome gains in the next 1-3 years.
So, we advise investors to start investing in quality stocks with sound earnings visibility with healthy corporate governance and reasonable valuations.
HDFC BANK
PAT in 2019 : 21000 Cr
Price @1200
HDFC bank Expected PAT in 2023: 42000 Cr
PAT for 2022 : 37000 Cr
Price @1300 levels
The profits post merger would be 65000-68000 cr.
The combined entity is available at 15 P/E & price is same despite profits having doubled.
Loan growth 20%
NII growth 15%
PAT growth 19%
The above growth on huge base.
Still many analysts thing
“Its below par result”
Avoid Noise & Time to buy compounder
PAT in 2019 : 21000 Cr
Price @1200
HDFC bank Expected PAT in 2023: 42000 Cr
PAT for 2022 : 37000 Cr
Price @1300 levels
The profits post merger would be 65000-68000 cr.
The combined entity is available at 15 P/E & price is same despite profits having doubled.
Loan growth 20%
NII growth 15%
PAT growth 19%
The above growth on huge base.
Still many analysts thing
“Its below par result”
Avoid Noise & Time to buy compounder
Wealthcreatures.com
The new Bull market leaders will slowly start showing up as the bear market keeps getting older Keep watching for a group of stocks that defy market and start moving with a pocket pivot volumes Potential Future Leaders - Nifty Auto & Few Auto ancillary…
Nifty Auto
In just one month is has moved almost 14%
10800 - 11000 zone To 12360 zone
Auto stocks That looks poised for upmove
M&M
Tata motors
Maruti
In just one month is has moved almost 14%
10800 - 11000 zone To 12360 zone
Auto stocks That looks poised for upmove
M&M
Tata motors
Maruti
Wealthcreatures.com
Auto Ancillary on upmove
Auto Ancillary are at same point where once I.T stocks where there before 2 years
Auto Ancillary can make big money in coming few Qtrs
Auto Ancillary can make big money in coming few Qtrs
Wealthcreatures.com
16200- 16300 zone can ACT as Resistance now Fresh Upmove only on close above 16300 Need few days Lower side support@ 16000
Keep this in mind
Nifty High - 16199.70
Nifty High - 16199.70
Trading pick
AFFEL INDIA
Days Low - 1026.10
Add bwt - 1040 - 1090 zone
Possible Test Levels # 1175/1225/1275+
TF - 1 To 3 months
S/L - 998 on cbsl or As per Risk
AFFEL INDIA
Days Low - 1026.10
Add bwt - 1040 - 1090 zone
Possible Test Levels # 1175/1225/1275+
TF - 1 To 3 months
S/L - 998 on cbsl or As per Risk
MEGHMANI FINCHEM
Meghmani Finechem commissions India’s largest Chlorinated Polyvinyl Chloride Resin (CPVC Resin) plant
Commissioned on time and within committed capex
Further strengthening our fully integrated complex
India’s ~ 95% demand of CPVC Resin is met through imports
The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India.
Despite a challenging external
environment, the plant has been commissioned on time and without any cost overrun, which is a testimony of the company’s strong project execution skills.
In India, CPVC resin demand is around 140 kilo tonnes per annum (KTPA) and it is expected to grow by around 13% CAGR over the next five years.
Approximately 95% of the CPVC resin demand of India is met through imports. MFL’s entry into this product is in line with the Central Government’s initiative of Aatmanirbhar Bharat and Make in India.
Meghmani Finechem commissions India’s largest Chlorinated Polyvinyl Chloride Resin (CPVC Resin) plant
Commissioned on time and within committed capex
Further strengthening our fully integrated complex
India’s ~ 95% demand of CPVC Resin is met through imports
The newly-commissioned facility with a production capacity of 30,000 tonnes per annum (TPA) is the largest of its kind in India.
Despite a challenging external
environment, the plant has been commissioned on time and without any cost overrun, which is a testimony of the company’s strong project execution skills.
In India, CPVC resin demand is around 140 kilo tonnes per annum (KTPA) and it is expected to grow by around 13% CAGR over the next five years.
Approximately 95% of the CPVC resin demand of India is met through imports. MFL’s entry into this product is in line with the Central Government’s initiative of Aatmanirbhar Bharat and Make in India.
Wealthcreatures.com
TIME TECHNO PLAST Once closed above 111 Shld See Upmove in next few Days
Time Technoplast
Ready for Ripe soon
Ready for Ripe soon
Last 1 to 2 week pattern all those stocks where earning are expected to he strong are on upmove
Markets getting Buy on Dips from sell on Rise
Markets getting Buy on Dips from sell on Rise
Wealthcreatures.com
GNFC Almost 11% Down Where's the bottom Difficult to say? No one knows it.... But Good Quality Stocks available at intrinsic Value From cmp 542 - 250 worth its holding cash 💸 in Books and bal 290 is for its bussiness Value for earning & other assets…
GNFC
Cmp - 655
RECOVERING FROM RECENT LOWS AND BOUNCING FROM INTRINSIC VALUE BUYING ZONE
Technically - Now Trading Above all important moving averages
Watch out for close above 675
Cmp - 655
RECOVERING FROM RECENT LOWS AND BOUNCING FROM INTRINSIC VALUE BUYING ZONE
Technically - Now Trading Above all important moving averages
Watch out for close above 675
Wealthcreatures.com
One stock which Possible fresh ATH IN NEXT 2 QTRS & Much higher levels in 12 to 16 Qtrs VERY few stocks which are holding up even in this Meltdown Support@ 150 - 145 zone
Sakar Healthcare
205
52wk/ATH - 212
Getting Ready to cross ATH 🔜
205
52wk/ATH - 212
Getting Ready to cross ATH 🔜